The Department of Veterans Affairs (VA), through its Network Contracting Office 22, intends to award a Sole Source contract for Lymphoseek and F-18 FDG Bulk supplies to Cardinal Health 414, LLC. This contract, a Firm Fixed-Price Indefinite Quantity/Indefinite Delivery (IDIQ), will support the VA Loma Linda Healthcare System (VALLHCS). Due to the proprietary nature of Lymphoseek, a radiopharmaceutical essential for identifying sentinel lymph nodes in melanoma patients, only Cardinal Health can fulfill this requirement. The notice states that responses should demonstrate a company's capability to supply similar items, though the intent is primarily informational, not a competitive solicitation. Interested parties may submit a capabilities statement by October 18, 2024, at 10:00 AM Pacific Time. The document emphasizes the sole-source nature of the procurement, indicating no further solicitations will be entertained unless significant evidence warrants reconsideration. The VA's goal is to maintain superior medical supply standards while ensuring regulatory compliance and operational efficiency.
The Department of Veterans Affairs (VA) Network Contracting Office 22 is announcing its intent to award a Sole Source contract for the procurement of Lymphoseek, a radiopharmaceutical, primarily for the VA Loma Linda Healthcare System. This contract, identified as Solicitation Number 36C26225Q0026, will be a Firm Fixed-Price Indefinite Quantity Indefinite Delivery (IDIQ) for a base year with four option years and will be awarded to Cardinal Health 414, LLC. The sole source determination, justified under FAR 6.302-1, was made based on market research that indicated only one responsible source could meet the requirements due to the proprietary nature of Lymphoseek, which is critical for identifying sentinel lymph nodes in melanoma patients. The estimated quantity for each year is 86 study doses of Lymphoseek. This notice serves as a preliminary announcement and is not a formal solicitation, inviting potential competitors to submit evidence of capability if they believe they can meet the requirements. All inquiries should be directed to the point of contact, Hestia Sim, with responses due by September 27, 2024, at 10:00 AM Pacific Time.